(Q47761051)

5 February 2018

title

A trial of IRX-2 in patients with squamous cell carcinomas of the head and neck (English)

1 reference

5 February 2018

author name string

Hadden J

1

1 reference

5 February 2018

Verastegui E

2

1 reference

5 February 2018

Barrera JL

3

1 reference

5 February 2018

Kurman M

4

1 reference

5 February 2018

Meneses A

5

1 reference

5 February 2018

Zinser JW

6

1 reference

5 February 2018

de la Garza J

7

1 reference

5 February 2018

Hadden E

8

1 reference

5 February 2018

publication date

1 August 2003

1 reference

5 February 2018

International Immunopharmacology

published in

1 reference

5 February 2018

volume

3

1 reference

5 February 2018

issue

8

1 reference

5 February 2018

page(s)

1073-1081

1 reference

5 February 2018

Strategies of immune reconstitution: effects of lymphokines on murine T cell development in vitro and in vivo

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2803%2900029-8

7 January 2021

Mixed interleukins and thymosin fraction V synergistically induce T lymphocyte development in hydrocortisone-treated aged mice

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2803%2900029-8

7 January 2021

Immunotherapy with natural interleukins and/or thymosin alpha 1 potently augments T-lymphocyte responses of hydrocortisone-treated aged mice

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2803%2900029-8

7 January 2021

Temporary regression of recurrent squamous cell carcinoma of the head and neck is achieved with a low but not with a high dose of recombinant interleukin 2 injected perilymphatically

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2803%2900029-8

7 January 2021

The treatment of zinc deficiency is an immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2803%2900029-8

7 January 2021

Zinc induces thymulin secretion from human thymic epithelial cells in vitro and augments splenocyte and thymocyte responses in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2803%2900029-8

7 January 2021

Interleukins and contrasuppression induce immune regression of head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2803%2900029-8

7 January 2021

Combination immunotherapy of squamous cell carcinoma of the head and neck: a phase 2 trial

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2803%2900029-8

7 January 2021

Thymic aging and T-cell regeneration

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2803%2900029-8

7 January 2021

T cell receptor gene deletion circles identify recent thymic emigrants in the peripheral T cell pool

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2803%2900029-8

7 January 2021

Immunological approach in the evaluation of regional lymph nodes of patients with squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2803%2900029-8

7 January 2021

Serological identification of human tumor antigens

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2803%2900029-8

7 January 2021

T cell defined tumor antigens

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2803%2900029-8

7 January 2021

Priming of tumor-specific T cells in the draining lymph nodes after immunization with interleukin 2-secreting tumor cells: three consecutive stages may be required for successful tumor vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2803%2900029-8

7 January 2021

A new era for cancer immunotherapy based on the genes that encode cancer antigens

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2803%2900029-8

7 January 2021

Cancer immunotherapy in clinical oncology

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2803%2900029-8

7 January 2021

An overview of cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2803%2900029-8

7 January 2021

10.1016/S1567-5769(03)00029-8

Identifiers

DOI

1 reference

5 February 2018

1 reference

5 February 2018